Consortium > Beneficiary
Medical University of Vienna
Doctoral Candidates: 2
Principal Investigator (Leader Work Package 6)
Priv.-Doz. Mag. Dr. Martin Schepelmann (Coordinator)
Institute of Pathophysiology and Allergy Research
The Medical University of Vienna (MUV) is one of the world’s leading medical universities, and hosts Europe’s largest hospital. It is one of the most important centers for postgraduate training and the promotion of young researchers in the international vocational training market. DC-MUV1 will be a member of the Inst. of Pathophysiology and Allergy Research (IPA).
Martin Schepelmann, the coordinator of eRaDicate, will supervise DC-MUV1 together with Enikö Kallay. Martin Schepelmann is a specialist in pathophysiology, molecular biology, medicinal chemistry, microscopy, and vascular biology. He was a Marie Curie ESR in the FP7-ITN “Multifaceted CaSR”.
Read his interview with the European Research Executive Agency about his career, cancer research, and advice for aspiring MSCA researchers.
Research Project
Project 5: Preventing OC, CRC and related metastasis
Principal Investigator
Prof. Lukas Kenner
Department of Pathology
Lukas Kenner, is a professor of Pathology at the Dept. of Clinical Pathology of the MUV and is specialized in WES genomics from formalin-fixed, paraffin-embedded (FFPE) patient samples in combination with radiomic features from PET/CT and PET/MRI diagnostics, spatial transcriptomics and spatial proteomics, fluorescence in situ hybridisation (FISH), and high throughput RNA/protein expression analysis for routine diagnostic purposes. He was the head of the Ludwig Boltzmann Institute for Cancer Research and participated in two doctoral networks.
Research Project
Project 6: Preventing PCa and related metastasis
Co-Principal Investigator (Leader Work Package 4 | Teaching)
Assoc. Prof. Dr. DI Isabella Ellinger
Institute of Pathophysiology and Allergy Research
Academic Supervisor DC-TG
Isabella Ellinger, a cell biologist, will supervise the DC-TG at MedUni Vienna and lead WP4 (teaching). Important areas of work are the investigation of the functions of the human placenta in health and disease, as well as the advancement of automated microscopy in collaboration with industry (Austrian company TissueGnostics GmbH) and scientific partners. In addition, she offers expertise and support in experimental design in the field of immunofluorescence microscopy and thus contributed to studies in various research areas (immunology, cancer research, pathophysiology).
